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Abstract
The microbial pathogen Toxoplasma gondii is an intracellular protozoan that
actively invades host cells and simultaneously creates a specialized
parasitophorous vacuole within which the parasite lives and replicates. The
parasite molecular machinery that drives establishment of the intracellular niche
is relatively well known. However, it is now emerging that Toxoplasma exploits
less well-understood host cell components to enable successful infection. Here,
we examined the role of host Wnt/β-catenin during T. gondii infection. Using
human fibroblasts and a mouse dendritic cell line, we found that infection
with Toxoplasma stimulated both upregulation and nuclear localization of βcatenin. Using a transwell experimental approach, we obtained data indicating
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that direct contact between parasites and cells is required for increased β-catenin
expression. To examine the functional consequences of augmented β-catenin
levels, we determined the effect of a panel of Wnt/β-catenin inhibitors on the
ability of T. gondii to successfully establish infection. Using both dendritic cells
and fibroblasts, we found up to 80% inhibition of infection in the presence of the
small molecule inhibitors. Subsequent efforts were directed towards determining
whether host β-catenin is required for the invasion event itself, or whether its role
is in maintenance of the parasitophorous vacuole in newly invaded cells.
Synchronized invasion analysis indicates that β-catenin is likely exploited by the
parasite during invasion, but may not be as vital later in infection. Finally, the
consequences of enhanced host β-catenin expression were assessed using a
panel of small molecule β-catenin enhancers. Drug-augmentation of host cell βcatenin promoted T. gondii infection in human foreskin fibroblasts, and
specifically assisted the parasite during invasion. Together, the results from this
study suggest that Toxoplasma gondii exploits host cell β-catenin during its
active invasion event, and give light to a previously unexplored mechanism for
inhibiting T. gondii infection.
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Introduction

Toxoplasma gondii background

Toxoplasma gondii is one the most successful known parasites, capable
of infecting virtually all warm blooded animals. Approximately 30% of the global
population is infected with T. gondii (Hunter and Sibley 2012), with certain
regions showing infection rates as high as 75% (Pappas et al. 2009). Infection
rates are higher in warm, humid climates, have been shown to increase with age,
and show difference in distribution between genders (Montoya and Liesenfeld
2004).

Primary infection is most commonly asymptomatic, or results in
nonspecific flu-like symptoms including fever, malaise and lymphadenopathy.
However, under certain conditions Toxoplasma infection can present extreme
pathogenicity. Severity of clinical symptoms is dependent on many factors
including host and parasite genotypes (Boothroyd and Grigg 2002), infection in
AIDS patients (Suzuki et al. 1996) or in a congenital setting (Jamieson et al.
2008). Pathology is particularly severe in immunocompromised individuals and
during transplacental infection of the fetus (Wormser et al. 2002).
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If the parasite successfully crosses the placental barrier, uncontrolled
replication in the fetus may result in retinochoroiditis, intellectual disability,
hydrocephaly, seizures and stillbirth (Suzuki et al.1996). Vertical transmission of
T. gondii occurs in approximately 40% of cases where the mother becomes
exposed to the parasite for the first time during pregnancy. Mothers infected prior
to pregnancy do not transmit the parasite to the fetus, except for cases where the
parasite becomes reactivated as a result of immunosuppression (Kaye 2011).

Diagnosis of congenital toxoplasmosis remains challenging, as 90% of
mothers are asymptomatic at the time of infection (Kravetz and Federman 2005).
Elevated serum IgM and IgG can be utilized as an indication of acute exposure
(Jones et al. 2003), and the level of IgM elevation can be assessed to determine
when exposure occurred. However, serum IgM levels can still incorrectly indicate
when infection occurred, as titers can remain elevated for up 18 months after
initial infection (Lopez et al. 2000). Further, elevated IgG levels confirm that a
patient has been exposed to Toxoplasma but does not indicate whether infection
was recent or occurred in the past, because low levels of anti-Toxoplasma IgG
will persist in the serum for the life of the patient. Thus, due to the inconsistency
of serological assays, the gold standard for diagnosis of congenital
toxoplasmosis is PCR testing of the amniotic fluid.
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Treatment strategies for congenital toxoplasmosis prioritize arresting
further replication of the parasite, especially within the eye to prevent permanent
damage to the retina and optic nerve (Soheilian et al. 2005). The Centers for
Disease Control and Prevention and World Health Organization currently
recommend pyrimethamine, sulfadiazine and leucovorin for treatment of
congenital toxoplasmosis. These medications have been shown to significantly
decrease signs and symptoms associated with congenital exposure to T. gondii
and are currently considered the standard of care (Rorman et al. 2006).

In HIV/AIDS or otherwise immunocompromised patients, infection or
reactivation of the parasite can also cause retinochoroiditis, or lead to
toxoplasmic encephalitis (TE) (Kim and Weiss 2004). TE can result in cerebral
mass lesion, is often associated with new-onset neurological signs and
symptoms, and may be fatal if left untreated. Highly active antiviral retroviral
therapy (HAART) has significantly reduced the incidence of TE in HIV patients by
slowing the collapse of the immune system. However, recent autopsy data still
indicates the presence of cerebral toxoplasmosis in 10 to 34% of HIV/AIDS
patients (Ayoade and Chandranesan 2019).

In non-immunodeficient individuals, ocular toxoplasmosis is the leading
cause of infectious retinochoroiditis (Toxoplasma retinochoroiditis), which may
result from acquired or congenital exposure to the parasite. Patients experiencing
Toxoplasma retinochoroiditis (TRC) report sudden onset hazy vision, vision loss,
3

pain and photophobia. Signs of TRC present as quiescent chorioretinal scarring
during the inactive phase, and as necrotizing chorioretinitis during the active
phase (Stokkermans and Havens 2019).

Currently, there is no consensus on the best treatment course for TRC,
however, the same 3 agents have been utilized to combat ocular toxoplasmosis
for the past 50 years. Oral pyrimethamine, sulfadiazine, along with prednisone
and folic acid is the most common treatment strategy for TRC, but treatment may
cause adverse effects in some patients. In particular, sulfadiazine can result in
severe hepatotoxicity, and cannot be administered to individuals with allergies to
sulfa drugs.

Toxoplasma gondii life cycle

T. gondii is an obligate intracellular protozoan parasite with three lifecycle
stages; sporozoites, tachyzoites and bradyzoites (Fig. 1). Sporozoite containing
oocysts are produced exclusively in the small intestine of felid species, the
parasite’s definitive host. Oocysts are shed through the feces of felines and can
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Figure 1. Toxoplasma gondii life cycle. Toxoplasma is reproduces sexually in
its definitive host, members of the felid family. Sporozoite containing oocyst are
shed by infected felids then ingested by rodents where the parasite differentiates
into bradyzoites within the rodent muscle tissue. Upon consuming infected
rodents, T. gondii repeats this life cycle. Oocysts can also contaminate water
supplies, generating a reservoir through with livestock can become infected, as
well as produce. Humans can become infected directly from contaminated water
sources, produce, consuming infected livestock where bradyzoites have
encysted, or through accidental ingestion of fecally shed oocysts. A final
extremely pathogenic reservoir of transmission is through vertical transmission,
which results in severe neonatal pathology.
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directly cause infection upon accidental ingestion, and also contaminate drinking
water and soil. After ingestion, sporozoites are released from the oocyst into the
intestinal lumen and invade the surrounding cells. After invasion, sporozoites
differentiate into tachyzoites, a life cycle stage that replicates in parasitophorous
vacuoles within host cells and is capable of infecting most nucleated cell types.
The tachyzoites rapidly replicate within the vacuoles, and subsequently release
factors causing the host cell to rupture. Tachyzoites then further disseminate
throughout the host via the blood and lymphatic system, with the potential to
infect any cell they contact.

Tachyzoites are responsible for the primary infection, and elicit all clinical
symptoms characterized as toxoplasmosis. In immune competent hosts, the
parasite is driven into quiescence, forming cysts within the muscle and nervous
tissue. After encysting, tachyzoites differentiate into slowly replicating
bradyzoites, responsible for the chronic phase of Toxoplasma infection.
Bradyzoites are controlled by immune competent hosts, but may be reactivated if
the host becomes immune-compromised.

Cysts containing bradyzoites in undercooked meat provide the most
common reservoir for human infection (Mead et al. 1999). Indeed, Toxoplasma is
third most common food borne illness resulting in hospitalization in the USA
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(Mead et al. 1999). After ingestion, the bradyzoite containing cysts rupture, and
the parasite is again able to invade in the intestinal lumen. At this point the
parasite again differentiates into the tachyzoite stage that causes primary
infection.

Innate immunity to Toxoplasma gondii

Because the tachyzoite stage of the parasite is responsible for all
Toxoplasma associated disease, the majority of studies focus exclusively on the
immune response associated with this stage. Following T. gondii inoculation,
neutrophils, inflammatory monocytes, dendritic cells (DCs) and macrophages are
recruited to the infected area. Toxoplasma derived profilin binds to Toll Like
Receptor (TLR) 11/12 on DCs and inflammatory monocytes, which stimulates the
production of IL-12 through the adaptor protein MyD88. Neutrophils and
macrophages are also important IL-12 reservoirs during infection and further
assist in promoting the Th1 response that is critical for controlling toxoplasmosis.
IL-12 is the primary cytokine trigger of this response and induces natural killer
(NK) cell and CD4+ T cell production of Interferon-gamma (IFN-γ) (Khan et al.
1994; Gazzinelli et al. 1993; Hunter et al. 1994). IFN-γ leads to macrophage
activation and promotes many intracellular processes necessary for killing the
parasite and arresting replication (Nathan et al. 1983).
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TLR activation elicits the first innate response during T. gondii infection.
While TLRs 2, 4, 9 and 11 are triggered by the parasite (Yarovinsky et al. 2005),
TLR11/12 activation is the best understood mechanism of IL-12 production.
TLR11 has been shown to induce IL-12 through the adaptor protein MyD88,
which is another critical factor for controlling Toxoplasma in vivo. MyD88 deficient
mice exhibit substantially increased morbidity when exposed to the parasite
(Scanga et al. 2002). However, human populations deficient in MyD88 do not
show increased susceptibility to toxoplasmosis, and absence of MyD88 does not
completely inhibit the IL-12 response to the parasite in murine models
(Sukhumavasi et al. 2008). Therefore, mechanisms of controlling infection and
IL-12 production independent of MyD88 must exist.

While several cell types are responsible for IL-12 production during
infection, DCs appear to be one of the most important contributors. Studies have
shown that mice with depleted DC populations, or MyD88 deficient DC
populations have lower systemic IL-12 levels and are more susceptible to
toxoplasmosis (Liu et al.; Hou et al. 2011). Further, treatment with exogenous IL12 restores resistance to both mouse models, indicating the importance of DC
derived IL-12 in controlling T. gondii infection.

Another interesting source of IL-12 during infection comes from
neutrophils, which have the cytokine prestored (Bliss et al. 2000). Neutrophils are
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among the first cells to migrate to the site of infection, and CXCR2 deficient mice
have increased parasite load within the CNS (Del Rio et al. 2001), indicating the
importance of neutrophil chemotaxis during the early stages of infection.
Furthermore, neutrophils are involved in other mechanisms of parasite control
including phagocytosis, release of extracellular traps and reactive chemical
species(Abi Abdallah et al.; Konishi and Nakao 1992).

As stated previously, IL-12 is vital for controlling infection because it
promotes IFN-γ production by NK cells and CD4+ T cells. IFN-γ activates
macrophages mediating T. gondii destruction. While it still not fully understood
how IFN-γ promotes macrophage killing of the parasite, studies have
demonstrated that this effect occurs in part due to nitric oxide (NO) production.
NO has been shown to directly inhibit parasite replication in macrophages and
other cell types (Suzuki, Orellana, et al. 1988) and macrophages stimulated with
IFN-γ show increased expression of inducible nitric oxide synthase (iNOS)
(Koide et al.1993), the enzyme directly responsible for catalyzing NO production.

IFN-γ also induces immunity related GTPases (IRGS), which have been
shown to facilitate parasite killing in multiple cell types ((Taylor et al. 2007). IRG
recruitment to the parasitophorous vacuole results in rupture of the vacuole,
releasing tachyzoites into the cytosol where they are digested.
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Adaptive immunity to Toxoplasma gondii

Unsurprisingly, CD8+ T cells are vital for controlling T. gondii infection,
because of their role in recognizing and destroying cells containing intracellular
pathogens. CD8+ T cells aid in controlling infection by acting as another source
of IFN-γ, and through perforin mediated lysis of infected cells (Denkers et al.
1997; R. Gazzinelli et al. 1992; Reichmann et al. 2000).

CD8+ T cell expansion during infection is caused by encounter between
naïve CD8+ T cells and their cognate antigen presented on MHCI molecules in
conjunction with costimulatory cytokine signaling. Studies in CD8+ T cell deficient
mice show increased mortality after T. gondii exposure (Denkers et al. 1997),
and additional research has demonstrated that resistance can be conferred
through adoptive transfer of CD8+ T cells from mice vaccinated with an
attenuated strain of the parasite (Gigley et al. 2009) or chronically infected mice
(Parker et al. 1991).

While DCs have been implicated in the stimulation the CD8+ T cell
response (Tait et al. 2010), further research is required to determine whether this
effect caused by DC presentation of antigen or IL-12 production (Liu et al. 2006).
Although the type of cells responsible for antigen presentation remains unclear, it
is widely accepted that CD8+ T cell expansion occurs when naïve CD8+ T cells
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encounter their cognate antigen on MHCI molecules on antigen presenting cells.
Surface Antigen 1 (SAG1) was among the first epitopes identified on MHCI
molecules to stimulate CD8+ T cell expansion (I. A. Khan et al. 1988). Later
studies have also identified dense granule proteins GRA4 and GRA6, and
rhoptry protein ROP7 as additional T. gondii derived epitopes recognized by
CD8+ T cells on MHCI molecules (Blanchard et al. 2008; Frickel et al. 2008).

CD4+ T cells also contribute to CD8+ T cell activation during infection.
Research using the attenuated T. gondii strains cpsII and ts-4 show CD4+ T cell
help is necessary to confer optimal CD8+ protection (Denkers, Scharton-Kersten,
et al. 1996; Jordan et al. 2009). Studies show that CD4+ T cells provide an
important source of IL-2 during CD8+ T cell activation. Furthermore, IL-2
depletion results in a decreased CD8+ T cell response and abrogates protection
(Denkers, Scharton-Kersten, et al. 1996).

In summary, CD8+ T cell activation is essential for controlling chronic
Toxoplasma infection. Indeed, in vivo depletion of CD8+ T cells in chronically
infected mice induces reactivation of the parasite and results in severe disease
(R. Gazzinelli et al. 1992). CD4+ T cells provide a crucial IL-2 source for CD8+ T
cell expansion and are required for optimal protection. CD8+ T cell mediated T.
gondii immunity is also facilitated by MCHI presentation of parasite derived
epitopes from to naïve CD8+ T cells expressing cognate T cell receptors.
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Immune Evasion Strategies

Toxoplasma employs a multitude of strategies to dampen and evade host
immune responses while establishing infection. During initial infection T. gondii
tachyzoites inhibit proinflammatory cytokines by interfering with translocation of
nuclear factor kappa-light-chain-enhancer of activated B (NF-κB) to the nucleus.
(Butcher et al. 2001). The parasite is also capable of preventing signal
transducer and activator of transcription 1 (STAT1) signaling, which renders
infected fibroblasts unresponsive to IFN-γ antimicrobial activity (Kim et al. 2007).
Additionally, infection causes upregulation of several anti-inflammatory pathways
including suppressor of cytokine signaling protein (SOCS) 1 (Stutz et al. 2012),
SOCS3 (Whitmarsh et al. 2011), and STAT3 (Butcher, Kim, Panopoulos, et al.
2005).

As mentioned earlier, IFN-γ is required for macrophage activation which
results in destruction of the parasite. However, this signal alone is typically not
sufficient for control of the infection, and a second signal is often required for
optimal protection. The best understood secondary signal for controlling
Toxoplasma infection comes from TNF-α and CD40 signaling (Andrade et al.
2006). Both of these pathways are controlled through NF-κB transcriptional
regulation, which is inhibited by parasite. Finally, NF-κB also promotes increased
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IL-12 production, providing another example of how NF-κB dysregulation is
advantageous for Toxoplasma gondii.

Toxoplasma motility and invasion mechanics

Toxoplasma utilizes a variety of complex mechanisms for motility and
invasion of host cells. Lacking common locomotive organelles like cilia and
flagella, Toxoplasma relies on unique process known as gliding for movement
(Sibley 2004). All apicomplexan sporozoites exhibit gliding motility, however this
process has been best studied in Toxoplasma tachyzoites. Gliding motility is
substrate dependent and relies on secretion of adhesins from the apical end of
the parasite which translocate to the posterior pole of the parasite. The parasite’s
motive force is generated by an actomyosin motor within the inner membrane
complex, and is dependent on F-actin polymerization within the outer and inner
membranes. Interaction between the cytosolic domains of adhesins and
intramembrane F-actin is then facilitated by aldolase, which allows the parasite to
propel itself along adhesins linked to the host cell membrane.

While gliding along the host cell membrane, it is hypothesized that the
parasite is assessing the surface for an optimal invasion site. Once an invasion
site is located, Toxoplasma becomes adherent to the host cell via its apical end.
Interestingly, cytochalasin D (cytD), an agent that inhibits actin polymerization,
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arrests gliding motility and invasion but leaves tachyzoites capable of
withstanding vigorous wash treatments without detaching from the host cell.
These findings suggest that T. gondii-mediated actin polymerization is required
for gliding motility and invasion, and that the parasite undergoes an actinindependent adhesion step prior to invasion (Carruthers and Boothroyd 2007).

The adhesion step is mediated by cigar shaped secretory organelles
known as micronemes, which are situated directly beneath the apical surface of
the tachyzoite. Increased calcium triggers the release of micronemal proteins
(MICs), which have been shown to have a multitude of adhesive domains known
to facilitate protein-protein and protein-carbohydrate adhesion (Soldati et al.
2001). Deletion of specific MIC genes, including MIC1 and MIC2 significantly
abrogates invasion in vitro, further suggesting the importance of MICs during
adhesion (Huynh et al. 2004; Cérède et al. 2005). In the final stage of adhesion,
the parasite is thought to commit to invasion upon secretion of another
micronemal protein, apical membrane antigen (AMA1), which brings the parasite
into intimate contact with host cell membrane.

After successfully adhering to the host cell, Toxoplasma initiates invasion
by expelling the contents of another apically located set of organelles known as
rhopties. Rhoptry neck (RON) proteins are associated exclusively with the neck
of the rhoptry organelle, and are deployed immediately before the remaining
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rhoptry proteins (ROPs). RON proteins complex with AMA1 to form a ring shaped
structure known as the moving junction (MJ). Multiple RONs are known to
associate with AMA1 to form the MJ with at least one, RON2, acting as
transmembrane protein. In this way, Toxoplasma gondii is capable of inserting its
own receptor in to the host cell membrane, which may partially account for
immense host repertoire (Carruthers and Boothroyd 2007).

After formation of the MJ, Toxoplasma gondii relies on its actomyosin
motor to propel itself into a nascent parasitophorous vacuole (PV) (DelormeWalker et al. 2012). It was previously accepted that the host cell is passive during
this invasion process (Gonzalez et al. 2009). However, more recent studies have
shown that toxofilin, a T. gondii derived actin binding protein, is responsible for
upregulation of host cell cortical actin dynamics (Delorme-Walker et al. 2012).
Additional findings have demonstrated that host cell actin is used to anchor the
MJ to the host cytoskeleton to properly facilitate entry of the tachyzoites
(Gonzalez et al. 2009). Further, host cell actin has been shown to transiently
localize with the nascent PV and can be detected in association with the
parasitophorous vacuole membrane (PVM) for up to 5 minutes after Toxoplasma
penetrates the host cell membrane (Gonzalez et al. 2009).

Because the host cell membrane and cytoskeleton are significant barriers
that physically block invasion, many microorganisms employ strategies to
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interfere with host cell cortical actin dynamics for optimal invasion. Indeed,
Toxoplasma appears to utilize toxofilin for this exact purpose (Delorme-Walker et
al. 2012). Toxofilin deficient tachyzoites exhibit impaired invasion dynamics
compared to wild type, and show atypical behaviors, such as sharp reorientation
and twisting at the host cell membrane after adhesion. Toxofilin knockout (KO)
tachyzoites eventually invade successfully, but do so much slower than wild type
parasites (Delorme-Walker et al. 2012). These findings further support the notion
that host cell cortical actin physically constrains the parasite from entry, and must
be reorganized by Toxoplasma to facilitate optimal infection.

While toxofilin has been shown to loosen the host cell actin mesh work, it
is currently unknown if host cell molecules are also associated with this process.
My research provides evidence that host β-catenin may be required for
Toxoplasma gondii to effectively reorganize cytoskeletal host actin during
invasion.

β-catenin background

Wnt/β-catenin dates back to the first metazoans, and is involved in a
broad spectrum of biological systems. β-catenin is an armadillo protein, and is
the center of the Wnt/β-catenin signaling axis. Since its discovery in 1982, βcatenin has been shown to function in a multitude of developmental processes in
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the hippocampus, cerebral cortex, spinal chord, neural crest, the hematopoietic
system and the reproductive system (Voronkov and Krauss 2013). Many
degenerative diseases and cancers are associated with β-catenin dysregulation
and aberrant behavior of other proteins within the signaling pathway. Axin
mutations are associated with increased β-catenin expression, and Axin
mutations are present within 11% of colorectal carcinoma cases (Wu et al. 2001).

β-catenin is a bifunctional molecule with roles in both transcriptional
regulation, and cellular adhesion processes. Under control of the Wnt/ β-catenin
axis, β-catenin primarily functions as a transcriptional coregulator of many genes
associated with neonatal development and oncogenesis. At steady state, βcatenin is constitutively expressed at low levels and actively marked for
degradation by a group of proteins commonly referred to as the β-catenin
destruction complex. This complex is comprised of many proteins organized
around axin, which acts as a scaffold for the destruction complex. As outlined by
figure 2, the presence of a Wnt ligand causes the transmembrane structures
LRP5/6 and frizzled to colocalize with the ligand. Under this confirmation, LRP5/6
and frizzled have a high affinity for axin, causing axin to dissociate from other
destruction complex proteins and translocate to the cell membrane. This results
in increased cytosolic β-catenin, as the β-catenin destruction complex
dissociates upon axin localizing to the cell membrane. As cytosolic β-catenin
levels rise, the molecule is able to translocate to the nucleus, causing
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upregulation of a multitude of genes. Interestingly, the data shown here
demonstrate that Toxoplasma infection mediates this effect, resulting
translocation of β-catenin to the nucleus, and increased β-catenin protein levels.

Outside of transcriptional regulation, β-catenin has an active role in the
catenin-cadherin complex (Fig 3). At the cell membrane, β-catenin assists in cellcell adhesions processes. Most studies suggest that β-catenin helps mediate cell
adhesion by acting as a bridge between E-cadherin and α-catenin, which binds
to cytoskeletal actin. However, other studies indicate that α-catenin is more likely
an allosteric protein (Drees et al. 2005). Protein fractionation experiments
indicate that α-catenin exists as both a monomer and homodimer, more readily
binding β-catenin or F-actin, respectively. Through this mechanism, β-catenin
dynamic regulation of cortical actin. When present, β-catenin allows for
remodeling of the cytoskeleton by binding with monomeric α-catenin. By binding
α-catenin and preventing it from complexing with itself, β-catenin allows actin
remodeling proteins, such as ARP2/3, to modulate cytoskeletal actin.

As mentioned earlier, T. gondii infection causes increased host β-catenin
protein levels. Here, I hypothesize that increased β-catenin may assist
Toxoplasma during infection by facilitating dysregulation of the host cell
cytoskeleton to promote optimal invasion.
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A

B

Figure 2. Canonical Wnt/ β-catenin pathway. A. In the absence of Wnt ligand,
constitutively expressed β-catenin is recruited to the destruction complex where
it is phosphorylated and ubiquitylated, then shuttled to the proteasome for
degradation. B. With Wnt ligand present, LRP5/6 and Frizzled (Fzd) colocalize,
causing the β-catenin complex to dissociate, allowing β-catenin to accumulate
in the cytosol and translocate to the nucleus. Once in the nucleus β-catenin
mediates downstream gene activity by acting as a transcriptional cofactor.
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A

B

Figure 3. β-catenin functions in cell adhesion and cytoskeletal
rearrangement. β-catenin assists in regulation of the cytoskeleton by
interacting with α-catenin. A. When bound to the cadherin and to α-catenin,
cytoskeletal F-actin can readily be rearranged. B. When not bound to β-catenin,
α-catenin dimerizes and stabilizes cortical F-actin, preventing it F-actin from
interacting with remodeling proteins.
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Materials and Methods

Parasite culture
RH-strain tachyzoites were initially purchased from American Type Tissue
Collection, then maintained by passage through human foreskin fibroblasts
cultures in DMEM (Corning) + 1% bovine growth serum (Hyclone). Fibroblasts
were grown to confluency then infected with RH-strain tachyzoites. Once
fibroblasts monolayers lysed from infection 100 μL – 2 mL of infected
supernatant was transferred to an uninfected fibroblast monolayer to maintain the
parasite culture.

In vitro culture of human foreskin fibroblasts and MutuDC1940 cells
Human foreskin fibroblasts (HFF) (Khan and Grigg 2017) and MutuDC1940
dendritic cells (DCs) (Fuertes Marraco et al. 2012) were cultured as previously
described. In brief, HFF were grown in a monolayer at 37°C in human fibroblast
medium (HFM) consisting of DMEM (Corning) containing 10% fetal bovine serum
(Life Technologies) and 1% penicillin (Life Technologies). MutuDC1940 cells
were grown at 37°C in a monolayer in RPMI (Corning) containing containing 10%
fetal bovine serum, 10mM HEPES (Life Technologies), 100uM penicillin (Life
Technologies) and 50 uM 2-mercaptoethanol.
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Synchronized invasion assays
As described by Kafsack et al., HFF monolayers were washed in Endo buffer (a
medium that allows for tachyzoite adherence to host cells but inhibits invasion)
pre-warmed to 37°C. HFF medium was replaced with Endo buffer, and RH
tachyzoites were resuspended in Endo buffer at 1000 tachyzoites/mL.
Tachyzoites in Endo buffer were then added to HFF monolayers and spun down
at 250 x g for 3 minutes to initiate contact. HFF monolayers and tachyzoites were
allowed to reequilibrate to 37° water bath allowing for attachment of tachyzoites
to the HFF. Endo buffer supernatant was carefully removed, and replaced with
HFM, allowing parasite invasion. Cells and parasites were then incubated at
37°C for 2 minutes, 20 minutes or 24 hours, medium was removed, and cells
were fixed with 1% paraformaldehyde (PFA) for 20 minutes then washed in PBS.

Differential intra and extracellular tachyzoite immunofluorescent staining
Intra and extracellular parasite staining was facilitated as described by Kafsack et
al., by taking advantage of the abundance of SAG1 antigens on parasite
membranes, which are masked on intracellular parasites by host cell membranes
prior to permeabilization. After fixation with PFA cell cultures on coverslips were
blocked with 5% normal mouse serum (NMS) and incubated with goat anti-SAG1
antibodies (Bio-Rad) (1:100) in PBS + 5% bovine serum albumin (BSA) for 1
hour. In this way extracellular parasites were labeled with anti-SAG1 antibody
whereas intracellular parasites remained unlabeled. Coverslips where then
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washed twice with PBS and twice with permeabilization buffer containing PBS +
0.1% saponin(P-B). Next, cell cultures were incubated with Texas Red
conjugated donkey anti-goat antibody (1:500) (Jackson ImmunoResearch
Laboratories) and FITC-conjugated rabbit anti-SAG1 antibody (1:1000) (Thermo
Fisher Scientific) in permeabilization buffer, exposing the intracellular SAG1
antigens to FITC-labeled antibody staining. Finally, coverslips were washed twice
in P-B and three times in PBS. The resulting stain showed extracellular parasites
bound with FITC and Texas Red conjugated antibodies, conveying a
yellow/orange coloration, while intracellular tachyzoites were bound only with
FITC-conjugated antibodies, allowing for differentiation between intracellular and
extracellular parasites.

Small Molecule β-catenin Inhibition assay
Fibroblast were grown to confluency on chamber slides (Thermo Fisher
Scientific), then pretreated with XAV939, JW55 or JW67 (Tocris) for 2 hours. The
fibroblast monolayers were then infected with 5x105 RH tachyzoites and
incubated at 37°C for 24 hours. Next, the chamber slides were fixed for 1 minute
in methanol and stained using Diff-Quik (Thermo Fisher Scientific). Finally,
infection percentages were determined via microscopy.
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Plaque assays
β-catenin inhibited before infection. Fibroblasts were grown to confluency in 24
well tissue culture plates (Falcon) in HFM. HFF cultures were pretreated with
HFM containing 500nM JW55 (Tocris) for 2 hours at 37°C then inoculated with
200 RH tachyzoites. HFF cultures were then spun at 250 x g for 3 minutes and
incubated at 37°C for 20 minutes to initiate contact between parasites and HFFs
and allow for invasion. Infected HFFs were washed 3x in PBS to remove
extracellular parasites and control wells were infected under identical conditions
with medium containing no JW55. HFF cultures were fixed in 100% methanol
then stained using Diff-Quik (Thermo Fisher Scientific) 5 days post-infection and
plaques were enumerated via microscopy.

β-catenin inhibited after infection. Fibroblasts were grown to confluency in 24 well
tissue culture plates (Falcon) in HFM. HFF cultures were then inoculated with
200 RH tachyzoites and incubated for 2 or 24 hours at 37°C. Infected HFFs were
next washed 3x in PBS to remove extracellular parasites, followed by addition of
HFM containing 500nM JW55. Control wells were subjected to identical
conditions with medium containing no JW55. Tissue culture plates were
incubated at 37°C for 5 days then stained using Diff-Quik (Thermo Fisher
Scientific). Plaques were quantified using microscopy.
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Drug toxicity assays
RH strain tachyzoites were incubated in HFM containing 250nM XAV939, 500nM
JW55, or DMSO carrier for 2 hours. Fibroblasts grown to confluency on 24 well
tissue culture plates (Falcon) were then infected with parasites from each
condition. Plaques were enumerated 5 days later using microscopy.

Drug toxicity on HFF cultures was assessed by incubating HFF monolayers on
24 well plates (Falcon) with HFM containing 250nM XAV939, 500nM JW55, or
DMSO for 2 hours. HFM was removed, then HFFs were washed with 1 mL PBS,
and incubated with 0.25% trypsin (Gibco) for 3 minutes. HFFs were recovered,
washed in PBS then stained with 0.4% trypan blue viability dye (Thermo Fisher
Scientific).

Western blotting
Supernatants were removed from cell culture before adding reducing SDS
sample buffer. Lysates were collected and proteins were separated by 10% SDSPAGE. After separation, proteins were transferred onto nitrocellulose, then
blocked for 2 hrs at room temperature with Tris-buffered saline containing 0.1%
TWEEN-20 and 5% nonfat dry milk (TBST + 5% NFDM). Next, blots were
washed 3x in TBST, followed by overnight incubation in primary antibody (anti-βcatenin or anti-GAPDH) (Cell Signaling Technology) diluted in TBST containing
5% BSA. Blots were then washed 4x in TBST and incubated for 2 hours at room
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temperature in TBST + 5% NFDM containing the secondary antibody (anti-rabbit
IgG conjugated to HRP) (Bio-Rad). Finally, blots were washed 6x in TBST and
proteins were visualized using a chemiluminescent detection system (Thermo
Fisher Scientific) and the ChemiDoc Imaging System (Bio-Rad).

Statistical Analysis
Statistical analyses were performed using Prism 6 (Graphpad). Unpaired, two
tailed Student’s t tests were used to calculate significance.
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Results

Toxoplasma gondii infection causes host cell β-catenin upregulation and
nuclear translocation

To investigate the impact of Toxoplasma infection on the host Wnt/βcatenin axis I infected Mutu1940 dendritic cells, a cell line transformed from
splenic murine CD8α+ DCs (Fuertes Marraco et al. 2012), with RH strain
tachyzoites then analyzed using immunofluorescence 5 hours later. Interestingly,
high levels of β-catenin were visible in the infected Mutu1940 cultures (Fig. 4A
and 4B), while these cells showed low β-catenin protein levels at steady state
(Fig. 4D and 4E), however, β-catenin nuclear translocation was clearly evident in
infected cultures (insets in Fig. 4A and B). To further asses this phenomenon,
human foreskin fibroblasts (HFFs) were infected under the same conditions.
Although a clear increase in β-catenin was not seen via immunofluorescence in
the HFFs 24 hours after infection with RH tachyzoites
(Fig. 4C and 4F), subsequent analysis with Western blot showed a significant
increase after infection (Fig. 6E and F).

Next, I sought to determine whether direct contact between host cells and
Toxoplasma was required for β-catenin upregulation. For this, transwell inserts
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containing RH tachyzoites were placed into Mutu1940 DC cultures then
examined via immunofluorescence 24 hours later.

Prior to obtaining these data, it was hypothesized that a Toxoplasmaderived factor secreted into the medium by the parasite may have been
responsible for the increase host cell β-catenin. Interestingly, DC cultures
exposed to tachyzoites in transwell inserts showed a β-catenin response
consistent with uninfected cells (Fig. 5A and B, E and F), while DC cultures
treated with RH again exhibited a significant increase in detectable β-catenin
(Fig. 5C and D). Therefore, these data suggest Toxoplasma must be in physical
contact with host cells in order to elicit the observed β-catenin response.

Earlier unpublished data from Cornell further corroborate these findings.
In this experiment, the β-catenin response to Toxoplasma was assessed in
mouse bone marrow derived dendritic cells (BMDCs), which exhibited high
steady-state levels of β-catenin protein (Fig 6A, No CHX). BMDCs were infected
with RH tachyzoites then whole cell lysates were collected after 5 hours and
examined using Western blot. Unexpectedly, β-catenin levels in the infected
BMDCs were similar to the uninfected cells (Fig 6A, No CHX).
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Figure 4. Toxoplasma infection causes increased β-catenin and nuclear
translocation. A and B, RH-infected Mutu1940 cells stained 24 hours post
infection for tachyzoites (green) and β-catenin (red). Nuclei stained with DAPI
(blue). The white arrow shows β-catenin in the nucleus of an infected cell
(enlarged in inset). Panel B depicts same field as A with β-catenin staining only.
D and E show uninfected Mutu1940 with staining as in A and B. C and F, human
fibroblasts infected with RH then stained as in A in B 24 hours after RH
treatment.
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Figure 5. Toxoplasma must be in direct contact with the host cell to induce
increased β-catenin. A and B, uninfected Mutu1940 cells with β-catenin stained
red and cell nuclei stained with DAPI (blue). A shows the overlay of both red and
blue channels, B shows β-catenin stain only. C and D, Mutu1940 cells infected
with RH tachyzoites (green) stained 24 hours after infection using the same
protocol as A and B. Inset of C shows anti-tachyzoite stain (green) and DAPI only.
E and F, Mutu1940 DCs incubated with RH in transwell inserts for 24 hours, then
stained as in and A and B, with F showing β-catenin staining only.
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Figure 6. Toxoplasma infection causes increases host β-catenin. A, cells were
either RH-infected or left noninfected (NI), then treated with cyclohexamide (CHX) 30
min later. Lysates were prepared 5 hours later and analyzed via Western Blot. B,
same protocol used as in A to compare RH (Type 1) to PTG (Type II). C, Mutu1940
cells were infected with RH strain parasites, then analyzed using Western Blot at the
specified times. D, ImageJ densitometric analyses from n=4 biological replicates. *,
p<0.05. E, Human fibroblasts were infected with RH at an MOI of 4, then lysates
were collected at the indicated times and assessed via Western Blot. F, densitometry
of n=3 biological replicates. *, p <0.05
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Because of the intricate balance between β-catenin synthesis and destruction
complex mediated degradation, it was suspected that high rates of new synthesis
may have obscured the effect of Toxoplasma infection on the Wnt/β-catenin
pathway in the BMDCs. Under this assumption, the experiment was repeated
using cyclohexamide (CHX) 30 minutes after infection to block de novo βcatenin synthesis. Consistent with recent data suggesting that Toxoplasma
directly deactivates the β-catenin destruction complex (He et al. 2018), β-catenin
protein levels remained high 5 hours after infection and were undetectable in
noninfected cells. Further investigation of BMDCs with Type II parasites (PTG)
demonstrated the same trend seen with Type I RH (Fig. 6B), indicating that the
increased β-catenin seen during RH infection is not unique to Type I parasites.

I then sought to more specifically characterize the timing of this response
after observing a clear increase in β-catenin in host cells at 5 and 24 hours postinfection. In the Mutu1940 cell line, a significant increase in β-catenin could be
seen as early as three hours, and remained evident up to 9 hours post infection
with RH tachyzoites (Fig 6C and D). Because immunofluorescent analysis of βcatenin in fibroblasts did not suggest as dramatic of trend as was seen in DC cell
lines, I also assessed the β-catenin response to RH tachyzoites in a timedependent manner via Western blot in HFFs. Fibroblasts were infected with RH
strain tachyzoites at a multiplicity of infection (MOI) of 4 parasites per cell, and
whole cell lysates were collected for analysis. β-catenin was again elevated

32

beginning 3 hours post infection and continued to increase up to 9 hours
following treatment with parasite (Fig. 6E and F).

Host cell β-catenin inhibition blocks Toxoplasma infection

Because Toxoplasma infection clearly caused increased host cell βcatenin protein levels, I next examined the impact of β-catenin inhibition during
infection. To accomplish this a panel of small molecule tankyrase (TNKS)
inhibitors was used. These drugs, JW55, and XAV939 have previously been
shown to specifically inhibit de novo β-catenin synthesis through tankyrase
mediated stabilization of the β-catenin destruction complex (Waaler et al. 2011;
WU et al. 2016; Hong et al. 2015).

Prior to experimentation involving Toxoplasma gondii with these inhibitors,
I investigated their potential for toxicity on human fibroblasts and parasites. HFF
cells were incubated with DMSO (the drug delivery vehicle), XAV939 and JW55
for 24 hours, then trypsinized cells was assessed using trypan blue viability dye.
The vehicle and drug treated fibroblasts did not exhibit a significant difference in
viability compared to the control (Fig 7A-D), demonstrating that the β-catenin
inhibitors and vehicle likely did not have a toxic effect on the HFF cells.

To the examine the potential for direct drug-mediated toxicity on the
parasite, RH tachyzoites were incubated in DMSO, XAV939 or JW55 for two
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hours. Tachyzoites from each condition were then added to fibroblast
monolayers, and plaques were enumerated 5 days after infection
microscopically. Similar to the plaque assays illustrated by figure 9, here lysed
groups of cells are referred to as plaques, and are representative of a singular
tachyzoite invasion event. Plaques can then be enumerated as quantitation of
how rapidly the infected culture is parasitized. As shown in figure 7E, similar
plaque counts were seen from parasites subjected to each condition, suggesting
that the β-catenin inhibitor panel did have direct toxic effects on the parasites.

After assessing the potential toxicity of the drug panel, fibroblast
monolayers were treated with JW55, XAV939 or an additional TNKS inhibitor,
JW67, then infected with RH tachyzoites. 24 hours after infection, the infected
HFF cultures were fixed and stained with Diff-Quik. Surprisingly, fibroblasts that
were treated with inhibitors showed drastically reduced infection rates compared
to controls (Fig 8). While these results suggest β-catenin plays a role in infection,
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Figure 7. β-catenin inhibitors are not directly toxic to host cells or
parasites. Fibroblasts were incubated with DMSO carrier (A) 250nM XAX939 (B)
and 500nM JW55 (C) for 24 hours, then cell viability was measured using Trypan
blue (D). E, Tachyzoites were incubated with inhibitor or carrier for 2 hours,
washed and then fibroblasts were infected for plaque enumeration 5 days later.
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Figure 8. β-catenin inhibition blocks Toxoplasma infection. Human
fibroblasts were preincubated for 2 hours with the indicated small molecule βcatenin inhibitors at the specified concentrations. Cells were infected with RH
tachyzoites then stained using Diff-Quik. Percent infection was manually
calculated using microscopy. Numbers above error bars specify percent
inhibition. *, p < 0.05. ** , p < 0.01
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it is also possible this effect could be the result inhibiting other β-catenin
independent TNKS mediated processes.

Next, I sought to elucidate which aspect of the infection process was
specifically impeded by TNKS inhibition. Because of β-catenin’s role during
cytoskeletal actin rearrangement (Drees et al. 2005), I suspected that β-catenin
inhibition was interfering with invasion or establishment and maintenance of the
parasitophorous vacuole. Using the pulse-invasion analysis (Fig. 9) and
differential staining technique (Fig. 10) previously used to model tachyzoite
invasion kinetics (Kafsack et al. 2007), I assessed the effect of host β-catenin
inhibition on T. gondii’s ability to successfully invade host cells.

In brief, this pulse-invasion technique utilizes Endo buffer, a medium that
permits tachyzoites to adhere to host cells without allowing invasion, to induce
synchronized invasion. This effect is mediated high K+ concentration in the Endo
buffer, which increases the internal pH of the parasite and arrests motility (Endo
et al. 1987). After the tachyzoites become adherent to host cells, the Endo buffer
is carefully removed and replaced with invasion-permissive medium which
causes the parasite’s inter pH to return to normal. This allows for accurate
quantitation of parasite invasion at early time points, as Toxoplasma typically
invades asynchronously. Differential staining of intracellular and extracellular
parasites is then required to properly identify invaded tachyzoites, as a large
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portion of parasites may have been adherent to host cells without having
undergone invasion at the timepoints investigated. Interestingly, after 2 minute,
20 minute and 24 hour synchronized invasion, fibroblasts treated with JW55
showed substantially lower infection percentages compared to fibroblasts that
were not treated with β-catenin inhibitor (Fig 11A and B).

While inhibition and pulse-invasion data indicate a potential a role of hostderived β-catenin during Toxoplasma gondii invasion, the function of this
molecule at later infection timepoints was still unclear. Therefore, the impact of
host β-catenin inhibition on parasite survivability after invasion was investigated
via plaque assay as illustrated by Figure 12. Fibroblast monolayers were treated
with JW55 2 hours prior to infection, or 2 or 24 hours post-infection with RH. 5
days later, cell cultures were stained using Diff-Quik and plaques were
enumerated via microscopy. As expected, fibroblasts that were pretreated with
JW55 showed fewer plaques compared to controls (Fig. 13A). However,
fibroblasts treated with inhibitor 2 hours after infection exhibited a less drastic
decrease in plaque count, and fibroblast monolayers treated with inhibitor 24
hours post-infection showed no significant difference in plaques compared to the
controls(Fig. 13 B and C). This effect may again be due to β-catenin’s role in
regulation of cortical actin. As previously shown, the parasitophorous
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Figure 9. Pulse-invasion assay schematic. HFF cells were plated and grown to
confluency, then incubated for 2 hours with 500nM JW55. HFM was then
removed and HFFs were washed with Endo buffer. Parasites suspended in Endo
buffer were added to HFF cultures, then spun down at 700RPM for 3 minutes.
Endo buffer was then replaced with invasion-permissive medium. Cultures were
fixed with PFA after 2 minutes, 20 minutes or 24 hours.
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becomes associated with host cell actin directly after invasion. However, this
event is transient, lasting only 5 minutes after the invasion event (Gonzalez et al.
2009), which may account for the necessity of host β-catenin only at early
infection timepoints.

Taken together, the results obtained by plaque assay and pulse-invasion
analysis indicate that Toxoplasma most likely requires host derived β-catenin
during the initial invasion event, but this molecule may not be as necessary after
the parasite has established infection. Plaque assay conditions where inhibitor
was added after infection were conducted specifically to assess the necessity of
β-catenin after the initial invasion event, and reveal that the parasite may not
require host β-catenin after penetrating the host cell membrane. Although
infection percentages were reduced under conditions where JW55 was added 2
hours post infection, this effect may be explained by the possibility that a
significant portion of the parasites could have still been in the process of actively
invading the HFF monolayers at that time.
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Figure 10. Differential intra/extracellular tachyzoite staining. A, schematic
outlining the procedure used to differentially stain intracellular and extracellular
parasites. B, left panel shows intracellular (I) and extracellular (E) tachyzoites
(green). Middle show red channel only (extracellular tachyzoites). Left panel shows
overlap of all channels, including fibroblast nuclei (blue).
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Figure 12. Plaque assay schematic. A. β-catenin inhibited before infection.
500nM JW55 was added to confluent fibroblast monolayers 2 hours prior to
infection with 200 RH-tachyzoites, followed by plaque enumeration 5 days later. B.
β-catenin inhibited after infection. Confluent fibroblast monolayers were infected
with 200 RH-strain tachyzoites, then 500nM JW55 was added 2 or 24 hours after
infection, followed by plaque enumeration 5 days later.
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Enhancing host cell β-catenin expression promotes Toxoplasma infection
in vitro.

After demonstrating the ability to prevent Toxoplasma infection through
inhibiting β-catenin, I investigated how enhancing β-catenin would impact the
parasite’s ability to successfully infect host cells. Glycogen synthase kinase 3β
(GSK3/β) is commonly targeted for inhibition to enhance expression of β-catenin
(Zhang et al. 2016). Therefore, I used a panel of small molecule GSK3/β
inhibitors to examine the outcome of increased host cell β-catenin during T.
gondii infection. 3F8 (Zhong et al.2009), Kenpaullone (Castelo-Branco et al.
2004) and CHIR 99021 (Naujok et al. 2014) are well characterized GSK3/β
inhibitors and were used to facilitate host cell β-catenin enhancement.

To test the effect of enhanced host β-catenin during Toxoplasma gondii
infection, human fibroblasts were treated with 3F8, Kenpaullone or CHIR 99021
then infected with RH-strain tachyzoites. 24 hours later, the infected HFF
monolayers were fixed and analyzed using immunofluorescence. Fibroblasts with
enhanced β-catenin demonstrated significantly higher infection rates compared
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Figure 14. β-catenin enhancers increase efficiency of infection. Human
fibroblasts were preincubated for 2 hours with 3F8, Kenpaullone (Ken) or CHIR
99021 (CHIR). A, cells (nuclei stained blue) were infected with RH tachyzoites
(green) then stained 24 hours later. B, percent infection was manually calculated
using microscopy. Data are representative of 3 independent experiments.
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to controls (Fig. 14 A and B), showing that increased host β-catenin augments
Toxoplasma infection.

After observing increased infection in HFFs treated with GSK3/β inhibitors,
I validated that GSK3/β inhibition was specifically upregulating β-catenin.
Kenpaullone was selected for more detailed study and used for subsequent βcatenin enhancement study. Fibroblasts cultures were treated with kenpaullone
for 2 hours, then whole cell lysates were collected and assessed by Western blot.
As shown by Figure 15, kenpaullone treatment increased both total, and active βcatenin levels.

Next, I investigated how enhanced β-catenin would affect the parasite,
specifically during invasion. Fibroblasts were pretreated with β-catenin
enhancers and synchronized invasion was induced using the same methodology
as in Figure 6. Unexpectedly, invasion was inconsistently augmented after
treatment with each CHIR 99021 and 3F8 (data not shown). However, treatment
with Kenpaullone caused a significant and reproducible increase in T. gondii
infection 20 minutes after inducing synchronized invasion (Fig. 16A and B).
Together, these data further validate the hypothesis that Toxoplasma exploits
host cell β-catenin during its active invasion process.
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Figure 15. Kenpaullone increases β-catenin in Human Fibroblasts. A,
Western blot analysis of HFF whole cell lysates collected after 2 hour incubation
with the indicated concentrations of Kenpaullone. B and C, densitometric
analysis of active and total β-catenin.
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Figure 16. Increased β-catenin promotes invasion. Fibroblasts were given a 2
hour pretreatment with 23μM Kenpaullone. A, pulse-chase invasion data were
assessed 20 minutes after synchronized infection using the staining technique
depicted in figure 7. Parasites stained green were used to calculate percent
infection (B) using microscopy.
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Discussion

While my research was in progress, another group reported that
Toxoplasma directly activates β-catenin by destabilizing its destruction complex.
He et. Al identified a novel Toxoplasma-derived protein, GRA18, which binds
GSK3/β causing increased host cell β-catenin, and nuclear translocation of βcatenin. Although these findings are similar to my experiments showing β-catenin
activation during infection, these researchers did not investigate the effect of βcatenin inhibition during infection.

My research has indicated that TNKS mediated β-catenin inhibition
inhibits Toxoplasma gondii infection. However, it cannot be disregarded that
TNKS enzymes are associated with a variety of signaling pathways outside of the
Wnt/β-catenin. Indeed, TNKS influences the cell cycle through its role in nuclear
mitotic apparatus protein (NuMA) interaction (Sbodio and Chi 2002), and TNKS
knockdown is shown to have an adverse impact on mitotic spindle functions.
However, HFFs do not continue to proliferate once they have reached
confluency, so it seems unlikely that TNKS function during the cell cycle would
impact T. gondii invasion. TNKS has also been shown to affect glucose transport,
acting as a positive regulator of GLUT4 translocation (Chi and Lodish 2000), thus
mediating glucose uptake. Additionally, TNKS is involved in telomere
maintenance by preventing telomerase activity on telomeres (Smith et al. 1998).
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TNKS is often involved in assembly and disassembly of large protein complexes.
While TNKS has been commonly targeted for β-catenin inhibition (WU et al.
2016; Waaler et al. 2011; Kim 2018; Hong et al. 2015), it is still possible that
TNKS inhibition blocked T. gondii infection in a β-catenin independent manner.
β-catenin silencing RNA (siRNA) would be an effective strategy for assessing
this issue, and would give additional insight regarding the consequences of βcatenin knockdown during Toxoplasma infection.

GSK/3β is another enzyme associated with a multitude of cellular
processes that was targeted solely for β-catenin upregulation. Here, GSK3/β
inhibition was shown to directly cause increased β-catenin protein levels, which
augmented Toxoplasma infection. Again, off target effects of GSK3/β inhibition
should not be overlooked, and increased infection in this context could be the
result of the role of GSK3/β in signaling cascades outside of the β-catenin
pathway. Although GSK3/β is a common drug target for β-catenin enhancement,
proper scientific rigor requires another more direct method of β-catenin
upregulation to more convincingly support the suggestion that increased βcatenin promotes infection. β-catenin overexpression has previously been
achieved through DNA transfection (Kim et al. 2000), and could be used to
further characterize the role of β-catenin during infection.
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Another quandary regarding β-catenin activation during Toxoplasma
infection is the nuclear translocation of β-catenin. As previously stated, β-catenin
acts as a transcriptional coregulator for a plethora of genes linked to
development. However, it is more likely that β-catenin’s role in cell adhesion is
exploited during infection. Perhaps nuclear translocation of the molecule is
simply a biproduct of the parasite dysregulating the β-catenin destruction
complex, with the main goal of increased β-catenin within the cytosol, particularly
near the cell membrane.

An additional interesting consideration regarding the extreme pathology T.
gondii in a neonatal context is the possibility that T. gondii induced β-catenin
dysregulation exacerbate the consequences of congenital infection. β-catenin
has been shown to regulate hippocampal and cerebral cortex development, as
well as development of the eye. Congenital Toxoplasma infection causes severe
pathology within the developing brain and eyes, which could be mediated in part
by the parasite’s ability to interfere with the Wnt/β-catenin axis.

β-catenin can also regulate genes unrelated to development. Interestingly,
Wnt activation of β-catenin has been shown to cause increased IL-8 expression
(Lévy et al. 2002). Although IL-8 is commonly known to induce neutrophil
recruitment, it also promotes angiogenesis. Further, Toxoplasma infection has
been shown to upregulate pro-angiogenic vascular endothelial growth factor
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(VEGF) and down regulate anti-angiogenic factors in vitro (Zhou et al. 2018).
Therefore, by activating the Wnt/β-catenin axis, T. gondii may also be
manipulating its host into providing increased nutrient supply to the cells it has
infected. Although tachyzoites are relatively short lived, increased blood supply
could aid in their replication. In addition, this effect would be particularly
beneficial during chronic infection. While the impact of T. gondii bradyzoites on
the Wnt/β-catenin pathway has not been examined, increased angiogenesis
surrounding chronically infected cells would certainly benefit the parasite.

Although it has not been conclusively proven, the role of β-catenin during
Toxoplasma infection appears to be most influential at the cell membrane. βcatenin inhibition results in significantly decreased infection, and specifically
appears to interfere with invasion. The most likely explanation for this
phenomenon relates to the role of β-catenin in cytoskeletal F-actin stabilization.
As described earlier, the catenin-cadherin complex most likely does not exist
statically. Figure 2 depicts this relationship showing that F-actin is stabilized by αcatenin homodimers, and can only be modified when α-catenin monomers are
bound to β-catenin.

The cortical cytoskeleton, which is primarily comprised of F-actin, is a
substantial physical barrier that many parasites, including Toxoplasma, and must
overcome in order to achieve intracellular infection. Studies show that T. gondii
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directly interferes with cortical F-actin using toxofilin (Delorme-Walker et al.
2012), and that F-actin protrusions are present on the nascent PV up to five
minutes after the T. gondii penetrates the host cell (Gonzalez et al. 2009).
Furthermore, the nascent PV has been shown to have a high affinity for actin
remodeling proteins, including the ARP2/3 complex. In this way, Toxoplasma
may manipulate the host cell cytoskeleton through upregulation of actin
remodeling processes, essentially reorganizing the actin filaments that would
otherwise physically block the parasite from invading.

As shown by Figure 17, β-catenin at the cell membrane has an affinity for
monomeric α-catenin. While in this conformation, α-catenin cannot stabilize
cytoskeletal F-actin, which may allow for Toxoplasma mediated reorganization.
By upregulating β-catenin, more binding sites for monomeric α-catenin likely
become available, thus increasing the avidity for T. gondii mediated cortical actin
remodeling. On the other hand, diminished β-catenin increases the likelihood for
α-catenin dimerization. Again, in its dimeric form α-catenin stabilizes cytoskeletal
F-actin, and reduces binding of actin remodeling factors, particularly ARP2/3.
Here, the hypothesized mechanism of inhibiting T. gondii infection by blocking βcatenin is based on the function of β-catenin at the cell membrane. If β-catenin is
inhibited, then α-catenin is more likely to exist in as a dimer, thus stabilizing actin
associated with the cytoskeleton and physically blocking Toxoplasma gondii from
invasion.
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Future investigation into the role of β-catenin during T. gondii would
benefit from in vivo investigation. Toxoplasma gondii is capable of infecting
virtually any nucleated cell type, but appears to preferentially infect certain cells
over others. Indeed, host cells expressing higher β-catenin levels could be
preferentially targeted by the parasite, and flow cytometric analysis could be
utilized to examine how host β-catenin impacts the parasite’s tropism.

While β-catenin itself may not be a viable drug target for treatment during
Toxoplasma gondii infection, this research gives valuable insight into the host cell
factors that may contribute to promote infection. Because of the wide range of
functions β-catenin has in organ function and development, targeting the
molecule during Toxoplasma infection would potentially elicit further pathology on
the host, especially within a neonatal setting. However, these data along with
other studies imply that T. gondii must reorganize the host cell cytoskeleton in
order to optimally invade. Although dysregulation of the Wnt/β-catenin axis
appears to have deleterious effects in both congenital and adult settings,
stabilizing the cytoskeleton through other means may prove to be a prudent
strategy for treating Toxoplasma gondii infection, neonatal or otherwise.
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A

B

Figure 17. β-catenin interaction with α-catenin at the cell membrane allows
T. gondii restructuring of cortical host cell F-actin. A. β-catenin at the cell
membrane binds monomeric α-catenin, preventing α-catenin from dimerizing and
stabilizing cytoskeletal F-actin. This allows T. gondii to restructure the host cell
actin at the cell membrane to facilitate optimal invasion. B. While β-catenin is
absent, α-catenin stabilizes the cytoskeleton and blocks the parasite from
restructuring cortical F-actin. Without the ability to manipulate the host
cytoskeleton as readily, Toxoplasma may be blocked from invading the host cell.
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